NO20025629L - Formulering - Google Patents

Formulering

Info

Publication number
NO20025629L
NO20025629L NO20025629A NO20025629A NO20025629L NO 20025629 L NO20025629 L NO 20025629L NO 20025629 A NO20025629 A NO 20025629A NO 20025629 A NO20025629 A NO 20025629A NO 20025629 L NO20025629 L NO 20025629L
Authority
NO
Norway
Prior art keywords
compositions
water
parenteral administration
propofol
edetate
Prior art date
Application number
NO20025629A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025629D0 (no
Inventor
David Buell Goodale
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20025629D0 publication Critical patent/NO20025629D0/no
Publication of NO20025629L publication Critical patent/NO20025629L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Colloid Chemistry (AREA)
  • Edible Oils And Fats (AREA)
NO20025629A 2000-05-25 2002-11-22 Formulering NO20025629L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012597.1A GB0012597D0 (en) 2000-05-25 2000-05-25 Formulation
PCT/GB2001/002259 WO2001089474A2 (fr) 2000-05-25 2001-05-22 Formulation

Publications (2)

Publication Number Publication Date
NO20025629D0 NO20025629D0 (no) 2002-11-22
NO20025629L true NO20025629L (no) 2003-01-08

Family

ID=9892262

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025629A NO20025629L (no) 2000-05-25 2002-11-22 Formulering

Country Status (18)

Country Link
US (3) US20030144356A1 (fr)
EP (1) EP1289503B1 (fr)
JP (1) JP2003535057A (fr)
KR (1) KR20030009501A (fr)
CN (1) CN1430503A (fr)
AT (1) ATE365538T1 (fr)
AU (2) AU5858801A (fr)
BR (1) BR0111136A (fr)
CA (1) CA2407764A1 (fr)
DE (1) DE60129134T2 (fr)
ES (1) ES2287128T3 (fr)
GB (1) GB0012597D0 (fr)
IL (1) IL152773A0 (fr)
MX (1) MXPA02011532A (fr)
NO (1) NO20025629L (fr)
NZ (1) NZ522365A (fr)
WO (1) WO2001089474A2 (fr)
ZA (1) ZA200208853B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166368C (zh) * 2003-02-26 2004-09-15 刘威 海狗油脂肪乳注射液、其制备方法及其在制备静脉注射剂中的应用
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
CA2572344A1 (fr) * 2004-07-01 2006-01-19 Schepens Eye Research Compositions et procedes servant a traiter des troubles et affections de l'oeil
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
EP1922060B1 (fr) * 2005-08-05 2009-01-14 Bharat Serums & Vaccines Ltd. Compositions d'emulsion de propofol pour administration intraveineuse presentant une efficacite de conservation
US20070149617A1 (en) * 2005-11-14 2007-06-28 Deckelbaum Richard J Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
WO2008036353A2 (fr) 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Émulsions de diglycérides oméga-3
CN101411685B (zh) * 2007-10-19 2011-04-20 上海医药工业研究院 一种静脉麻醉药2,6-二异丙基苯酚微乳组合物及其制备方法
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
WO2010141648A2 (fr) 2009-06-05 2010-12-09 Allergan, Inc. Larmes artificielles et utilisations thérapeutiques
WO2011047091A1 (fr) * 2009-10-13 2011-04-21 Martek Biosciences Corporation Méthodes de traitement de lésions traumatiques du cerveau
WO2011103512A1 (fr) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Émulsions d'acide gras sans dha
WO2011103514A1 (fr) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Émulsions de triglycéride dha
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
EP2560633B8 (fr) * 2010-04-23 2020-08-12 The Government of the United States, as represented by The Secretary of the Army Compositions intraveineuses d'acides gras oméga-3 et méthode d'utilisation
US11236351B2 (en) 2010-05-17 2022-02-01 Dow Agrosciences Llc Production of DHA and other LC PUFAs in plants
WO2011149854A2 (fr) * 2010-05-25 2011-12-01 Eric Kuhrts Formulations stables d'acides gras
ES2649896T3 (es) * 2010-07-06 2018-01-16 Glaxosmithkline Biologicals Sa Emulsiones catiónicas de aceite en agua
PT2627173E (pt) 2010-10-12 2015-07-24 Medicines Co Formulações de clevidipina em emulsão contendo agentes antimicrobianos
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
US20120251685A1 (en) * 2011-04-04 2012-10-04 Martek Biosciences Corporation Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same
LT2720701T (lt) * 2011-06-15 2017-11-10 Stable Solutions Llc Terapinis parenterinio krilių aliejaus taikymas
US10052352B2 (en) 2011-06-15 2018-08-21 Stable Solutions Llc Therapeutic application of parenteral krill oil
TW201307553A (zh) * 2011-07-26 2013-02-16 Dow Agrosciences Llc 在植物中生產二十二碳六烯酸（ｄｈａ）及其他長鏈多元不飽和脂肪酸（ｌｃ－ｐｕｆａ）之技術
CN102366404B (zh) * 2011-10-20 2015-10-07 四川百利药业有限责任公司 一种丙泊酚中/长链脂肪乳剂
WO2014033751A2 (fr) * 2012-08-16 2014-03-06 Emcure Pharmaceuticals Limited Composition pharmaceutique de propofol
US10070643B2 (en) 2013-03-28 2018-09-11 The Trustees Of Columbia University In The City Of New York Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
ES2607715B1 (es) * 2015-10-01 2018-01-17 Solutex Na, Lcc Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478414A (en) * 1992-01-31 1995-12-26 Aluminum Company Of America Reflective aluminum strip, protected with fluoropolymer coating and a laminate of the strip with a thermoplastic polymer
US5637404A (en) * 1992-01-31 1997-06-10 Aluminum Company Of America Reflective aluminum strip
CZ285795B6 (cs) * 1994-02-04 1999-11-17 Scotia Lipidteknik Ab Emulse oleje ve vodě, její použití a farmaceutický prostředek, který ji obsahuje
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
DK1105096T3 (da) * 1998-08-19 2004-03-08 Skyepharma Canada Inc Injicerbare vandige propofoldispersioner
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6582723B2 (en) * 2001-05-03 2003-06-24 Wayne F. Gorsek Cancer immune composition for prevention and treatment of individuals

Also Published As

Publication number Publication date
BR0111136A (pt) 2003-04-08
DE60129134D1 (en) 2007-08-09
AU5858801A (en) 2001-12-03
WO2001089474A3 (fr) 2002-03-07
NZ522365A (en) 2004-09-24
JP2003535057A (ja) 2003-11-25
EP1289503B1 (fr) 2007-06-27
KR20030009501A (ko) 2003-01-29
CN1430503A (zh) 2003-07-16
AU2001258588B2 (en) 2005-05-19
CA2407764A1 (fr) 2001-11-29
WO2001089474A2 (fr) 2001-11-29
ATE365538T1 (de) 2007-07-15
US20060257433A1 (en) 2006-11-16
DE60129134T2 (de) 2008-02-28
EP1289503A2 (fr) 2003-03-12
ES2287128T3 (es) 2007-12-16
NO20025629D0 (no) 2002-11-22
ZA200208853B (en) 2004-02-19
MXPA02011532A (es) 2003-04-25
IL152773A0 (en) 2003-06-24
GB0012597D0 (en) 2000-07-12
US20080312338A1 (en) 2008-12-18
US20030144356A1 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
NO20025629L (no) Formulering
EA200601460A1 (ru) Препарат микроэмульсии с высокой концентрацией пропофола для анестезирующих применений
ATE497384T1 (de) Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
EE200300109A (et) Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon
KR870002834A (ko) 유제조성물의 제조방법
DK1238677T3 (da) Parenterale fedtemulsioner, der omfatter edetat som konserveringsmiddel
IL114212A0 (en) Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
MA28748B1 (fr) Applications galeniques de melanges auto-emulsionnants d'excipients lipidiques
BRPI0519142A2 (pt) espuma de bomba alcoàlica
CR7614A (es) Preparaciones de insulina acida con estabilidad mejorada
JP2003535057A5 (fr)
BR0206511A (pt) Formulação parenteral para análogos de epotilona
MA23344A1 (fr) Nouvelles compositions d'emulsions
BR0206509A (pt) Métodos de administração de análogos de epotilona para o tratamento de câncer
AR033221A1 (es) Composicion farmaceutica finamente autoemulsionable
CO5560559A2 (es) Formulacion de suspension oral estabilizada
ATE516016T1 (de) Selbstemulgierende formulierungen von cetp- hemmern
PE20021017A1 (es) Composicion parenteral reconstituible
EA200300047A1 (ru) Прозрачное водное анестезирующее средство
DK1267831T3 (da) Hidtil ukendt selvemulgerende system til lægemiddelindgift
BR0009214A (pt) Composições aquosas estáveis contendo umcomposto de silìcio
MXPA02011531A (es) Beneficio de superviviencia.
EA200200217A1 (ru) Парентеральная цисплатиновая эмульсия
BRPI0520550A2 (pt) fórmulas anti-helmìnticas
CL2004001105A1 (es) Composicion en forma de concentrado de suspension liquida que comprende sulfonilureas suspendidas, uno o mas compuestos activos disueltos en un solvente organico, emulsionantes no ionicos y hasta 30% de agua, su procedimiento de preparacion, metodo p

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application